Percutaneous left atrial appendage occlusion in patients with a cardiac implantable electronic device
| العنوان: | Percutaneous left atrial appendage occlusion in patients with a cardiac implantable electronic device |
|---|---|
| المؤلفون: | D. P. Staal, M. Maarse, E. Aarnink, M. F. M. Huijboom, B. G. S. Abeln, B. J. M. W. Rensing, M. J. Swaans, V. F. Van Dijk, L. V. A. Boersma |
| المساهمون: | Graduate School, Cardiology, ACS - Heart failure & arrhythmias |
| المصدر: | Journal of interventional cardiac electrophysiology. Springer Netherlands |
| بيانات النشر: | Springer Science and Business Media LLC, 2023. |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Pacemaker, Stroke, Cardiac implantable electronic device, Physiology (medical), Implantable cardioverter defibrillator, Left atrial appendage occlusion, Cardiology and Cardiovascular Medicine, Atrial fibrillation |
| الوصف: | Background Left atrial appendage occlusion (LAAO) may be a viable option for stroke prevention in patients with non-valvular atrial fibrillation and a contraindication for oral anticoagulation. No evidence evaluating the safety of this procedure in patients with a cardiac implantable electronic device (CIED) exists. The aim of this study was to evaluate whether CIED function is affected by LAAO and to explore LAAO procedural characteristics and complications in patients with a CIED. Methods This single-center cohort study included consecutive patients scheduled for percutaneous LAAO. Patients with a CIED prior to LAAO were selected and compared to the patients without CIED, concerning procedural characteristics and peri-procedural complications. In the group of patients with CIEDs, essential pacemaker integrity parameters were compared before and after the procedure to detect possible micro and macro lead displacements. Results Thirty-one patients with CIED were scheduled for LAAO (age 73.7 ± 5.4 years, 65% males, CHA2DS2-VASc 4.3 ± 1.5, and HAS-BLED 3.3 ± 1.0). The 245 patients without CIED were younger, and HAS-BLED-score was slightly lower (69.4 ± 8.2 years, p p = 0.022). Patients without CIED more frequently underwent LAAO combined with catheter ablation (p = 0.002). All other procedural characteristics were comparable between both groups. No visible lead displacement was observed on chest X-ray after LAAO. Additionally, no differences in impedance, threshold, or intracardiac sensing in various CIED lead locations were found prior versus post LAAO. Conclusion This study supports the feasibility and safety of LAAO in patients with a CIED. |
| تدمد: | 1572-8595 1383-875X |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72445a7a292f1de406f8b35035b4e080 https://doi.org/10.1007/s10840-023-01512-0 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....72445a7a292f1de406f8b35035b4e080 |
| قاعدة البيانات: | OpenAIRE |
Find this article in full text from Springer Verlag. | تدمد: | 15728595 1383875X |
|---|